http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 07 May 2026 17:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html <p>VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market.</p> <p>The shipment included 1,000 one-gram live resin vape cartridges produced as finished goods under Good Manufacturing Practices (GMP). Fully manufactured, packaged, labelled, and released through HYTN’s GMP quality systems, these market-ready cartridges demonstrate HYTN’s capability http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html Thu, 30 Apr 2026 17:01:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html <p>VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market.</p> <p>The shipment included 1,000 one-gram live resin vape cartridges produced as finished goods under Good Manufacturing Practices (GMP). Fully manufactured, packaged, labelled, and released through HYTN’s GMP quality systems, these market-ready cartridges demonstrate HYTN’s capability http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html Thu, 30 Apr 2026 17:01:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html <p>VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market.</p> <p>The shipment included 1,000 one-gram live resin vape cartridges produced as finished goods under Good Manufacturing Practices (GMP). Fully manufactured, packaged, labelled, and released through HYTN’s GMP quality systems, these market-ready cartridges demonstrate HYTN’s capability http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html Thu, 30 Apr 2026 17:01:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html <p>VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market.</p> <p>The shipment included 1,000 one-gram live resin vape cartridges produced as finished goods under Good Manufacturing Practices (GMP). Fully manufactured, packaged, labelled, and released through HYTN’s GMP quality systems, these market-ready cartridges demonstrate HYTN’s capability http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html Thu, 30 Apr 2026 17:01:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html <p>VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market.</p> <p>The shipment included 1,000 one-gram live resin vape cartridges produced as finished goods under Good Manufacturing Practices (GMP). Fully manufactured, packaged, labelled, and released through HYTN’s GMP quality systems, these market-ready cartridges demonstrate HYTN’s capability http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html Thu, 30 Apr 2026 17:01:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html <p>VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market.</p> <p>The shipment included 1,000 one-gram live resin vape cartridges produced as finished goods under Good Manufacturing Practices (GMP). Fully manufactured, packaged, labelled, and released through HYTN’s GMP quality systems, these market-ready cartridges demonstrate HYTN’s capability http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html Thu, 30 Apr 2026 17:01:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html <p>VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market.</p> <p>The shipment included 1,000 one-gram live resin vape cartridges produced as finished goods under Good Manufacturing Practices (GMP). Fully manufactured, packaged, labelled, and released through HYTN’s GMP quality systems, these market-ready cartridges demonstrate HYTN’s capability http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html Thu, 30 Apr 2026 17:01:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html <p>VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market.</p> <p>The shipment included 1,000 one-gram live resin vape cartridges produced as finished goods under Good Manufacturing Practices (GMP). Fully manufactured, packaged, labelled, and released through HYTN’s GMP quality systems, these market-ready cartridges demonstrate HYTN’s capability http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html Thu, 30 Apr 2026 17:01:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Globe+Newswire/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html <p>VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market.</p> <p>The shipment included 1,000 one-gram live resin vape cartridges produced as finished goods under Good Manufacturing Practices (GMP). Fully manufactured, packaged, labelled, and released through HYTN’s GMP quality systems, these market-ready cartridges demonstrate HYTN’s capability http://www.streetinsider.com/Globe+Newswire/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html Thu, 30 Apr 2026 17:01:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070